Title

Downregulation of Tumor Growth and Invasion by Redox-Active Nanoparticles

Authors

Authors

L. Alili; M. Sack; C. von Montfort; S. Giri; S. Das; K. S. Carroll; K. Zanger; S. Seal;P. Brenneisen

Comments

Authors: contact us about adding a copy of your work at STARS@ucf.edu

Abbreviated Journal Title

Antioxid. Redox Signal.

Keywords

HUMAN DERMAL FIBROBLASTS; NADPH OXIDASE; CERIUM OXIDE; SOLID TUMORS; CELLS; MELANOMA; CANCER; APOPTOSIS; ANTIOXIDANT; ACTIVATION; Biochemistry & Molecular Biology; Endocrinology & Metabolism

Abstract

Aims: Melanoma is the most aggressive type of malignant skin cancer derived from uncontrolled proliferation of melanocytes. Melanoma cells possess a high potential to metastasize, and the prognosis for advanced melanoma is rather poor due to its strong resistance to conventional chemotherapeutics. Nanomaterials are at the cutting edge of the rapidly developing area of nanomedicine. The potential of nanoparticles for use as carrier in cancer drug delivery is infinite with novel applications constantly being tested. The noncarrier use of cerium oxide nanoparticles (CNPs) is a novel and promising approach, as those particles per se show an anticancer activity via their oxygen vacancy-mediated chemical reactivity. Results: In this study, the question was addressed of whether the use of CNPs might be a valuable tool to counteract the invasive capacity and metastasis of melanoma cells in the future. Therefore, the effect of those nanoparticles on human melanoma cells was investigated in vitro and in vivo. Concentrations of polymer-coated CNPs being nontoxic for stromal cells showed a cytotoxic, proapoptotic, and anti-invasive capacity on melanoma cells. In vivo xenograft studies with immunodeficient nude mice showed a decrease of tumor weight and volume after treatment with CNPs. Innovation: In summary, the redox-active CNPs have selective pro-oxidative and antioxidative properties, and this study is the first to show that CNPs prevent tumor growth in vivo. Conclusion: The application of redox-active CNPs may form the basis of new paradigms in the treatment and prevention of cancers.

Journal Title

Antioxidants & Redox Signaling

Volume

19

Issue/Number

8

Publication Date

1-1-2013

Document Type

Article

Language

English

First Page

765

Last Page

778

WOS Identifier

WOS:000323203200002

ISSN

1523-0864

Share

COinS